Literature DB >> 33406191

Traceless Staudinger ligation enabled parallel synthesis of proteolysis targeting chimera linker variants.

Troy A Bemis1, James J La Clair, Michael D Burkart.   

Abstract

A parallel, one-pot assembly approach to proteolysis targeting chimeras (PROTACs) is demonstrated utilizing activated esters generated in situ, and traceless Staudinger ligation chemistry. The method described allows for rapid structure-activity relationship studies of PROTAC linker variants. Two previously studied systems, cereblon and BRD4 degraders, are examined as test cases for the synthetic method. The two related strategies to assemble PROTAC linker variants discussed can accommodate the chromotographic separations capabilities of labs of many sizes and incorporates commercially available degrader building blocks, thereby easing synthetic entry into PROTAC chemical space.

Entities:  

Year:  2021        PMID: 33406191      PMCID: PMC7962863          DOI: 10.1039/d0cc05395c

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  43 in total

Review 1.  The Staudinger ligation-a gift to chemical biology.

Authors:  Maja Köhn; Rolf Breinbauer
Journal:  Angew Chem Int Ed Engl       Date:  2004-06-14       Impact factor: 15.336

2.  One-pot chemo-enzymatic synthesis of reporter-modified proteins.

Authors:  Andrew S Worthington; Michael D Burkart
Journal:  Org Biomol Chem       Date:  2005-11-24       Impact factor: 3.876

3.  Chemoselective Synthesis of Lenalidomide-Based PROTAC Library Using Alkylation Reaction.

Authors:  Xing Qiu; Ning Sun; Ying Kong; Yan Li; Xiaobao Yang; Biao Jiang
Journal:  Org Lett       Date:  2019-05-08       Impact factor: 6.005

4.  Solid-phase synthesis for thalidomide-based proteolysis-targeting chimeras (PROTAC).

Authors:  S Krajcovicova; R Jorda; D Hendrychova; V Krystof; M Soural
Journal:  Chem Commun (Camb)       Date:  2019-01-17       Impact factor: 6.222

5.  Practical synthesis of a phthalimide-based Cereblon ligand to enable PROTAC development.

Authors:  Jasmin Lohbeck; Aubry K Miller
Journal:  Bioorg Med Chem Lett       Date:  2016-09-19       Impact factor: 2.823

Review 6.  PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future.

Authors:  Mariell Pettersson; Craig M Crews
Journal:  Drug Discov Today Technol       Date:  2019-02-13

Review 7.  Automating drug discovery.

Authors:  Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2017-12-15       Impact factor: 84.694

8.  Water-soluble phosphinothiols for traceless staudinger ligation and integration with expressed protein ligation.

Authors:  Annie Tam; Matthew B Soellner; Ronald T Raines
Journal:  J Am Chem Soc       Date:  2007-08-22       Impact factor: 15.419

9.  Structural basis of PROTAC cooperative recognition for selective protein degradation.

Authors:  Morgan S Gadd; Andrea Testa; Xavier Lucas; Kwok-Ho Chan; Wenzhang Chen; Douglas J Lamont; Michael Zengerle; Alessio Ciulli
Journal:  Nat Chem Biol       Date:  2017-03-13       Impact factor: 15.040

10.  Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs.

Authors:  Miriam Girardini; Chiara Maniaci; Scott J Hughes; Andrea Testa; Alessio Ciulli
Journal:  Bioorg Med Chem       Date:  2019-02-22       Impact factor: 3.641

View more
  2 in total

Review 1.  PROTACs for BRDs proteins in cancer therapy: a review.

Authors:  Chao Wang; Yujing Zhang; Shanbo Yang; Wujun Chen; Dongming Xing
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

2.  A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions.

Authors:  Le Guo; Yaxian Zhou; Xueqing Nie; Zhongrui Zhang; Zhen Zhang; Chunrong Li; Taobo Wang; Weiping Tang
Journal:  Eur J Med Chem       Date:  2022-04-01       Impact factor: 7.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.